Garrett M. Fitzmaurice, ScD

  • 10Articles
  • 56.4KReads
  • 2012–2024Active
  • 25Collaborators
  • 727Citations

About

Garrett M. Fitzmaurice, ScD, is affiliated with McLean Hospital and Harvard Medical School. His publications from 2012 to 2024 focus on clinical topics including borderline personality disorder, addiction, bipolar disorder, neurodevelopmental conditions, neuroleptic malignant syndrome, and suicide. His research includes longitudinal studies on symptomatic remission, recovery, and substance use, as well as randomized controlled trials addressing cognitive remediation and psychoeducation. He frequently collaborates with Mary C. Zanarini, Frances R. Frankenburg, and other colleagues.

Publications

JCP
Symptomatic Remission and Overall Recovery From BPD
Original Research

Symptomatic Remission and Overall Recovery From BPD

October 23, 2024

Over 24 years, patients with BPD were significantly slower to achieve remission or recovery than patients with other personality disorders. Ultimately, however, both groups achieved similarly high rates of...
, , , et al
JCP
Symptomatic Disorders Comorbid with Borderline Personality Disorder Over Time
Original Research

Symptomatic Disorders Comorbid with Borderline Personality Disorder Over Time

August 7, 2024

Findings suggest that the absence of substance use disorders is the strongest predictor of achieving recovery from BPD.
, , , et al
JCP
Smoking in Borderline Patients
Original Research

Smoking in Borderline Patients

November 8, 2023

This study assessed predictors of smoking in borderline personality disorder and compared smoking prevalence in recovered vs non-recovered patients.
, , , et al
JCP
Article

Opioid Abstinence Over 42-Month Follow-Up

March 26, 2019

Which treatments are strongly associated with opioid abstinence over time among patients with prescription opioid dependence: Opioid agonists? Outpatient counseling? Mutual-help group attendance?
, , , et al
JCP
Original Research

Deaths in Borderline Personality Disorder Patients

January 22, 2019

Borderline personality disorder (BPD) is associated with increased suicidality, but less is known about other forms of premature death in individuals with BPD. Read this article to learn how...
, , , et al
JCP
Original Research

Cognitive Remediation in Bipolar Disorder

October 17, 2017

Cognitive dysfunction in bipolar disorder is a strong predictor of disability, poor quality of life, and longer time to recovery. Could cognitive remediation, a behavioral intervention used successfully in...
, , , et al
JCP
Original Research

Psychoeducation for Borderline Personality Disorder

July 11, 2017

Although psychoeducation can benefit patients with borderline personality disorder, the lack of trained personnel and the cost of implementation have prevented widespread adoption of this treatment. Read this article...
, , , et al
JCP
Article

Initial Response as a Predictor of 12-Week Buprenorphine-Naloxone Treatment Response in a Prescription Opioid-Dependent Population

December 23, 2014

, , , et al
JCP
Original Research

The Use of Prescription Opioid Medication by Patients With Borderline Personality Disorder and Axis II Comparison Subjects: A 10-Year Follow-Up Study

January 7, 2014

, ,
JCP
Original Research

Poor Sleep at Baseline Predicts Worse Mood Outcomes in Patients With Co-Occurring Bipolar Disorder and Substance Dependence

January 10, 2012

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe